Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials∗ ∗ A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade) Study Group and the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibition in STENTing) Study Group can be found in the Appendices.
Titel:
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials∗ ∗ A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade) Study Group and the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibition in STENTing) Study Group can be found in the Appendices.
Auteur:
Lincoff, A.Michael LeNarz, LeRoy A Despotis, George J Smith, Peter K Booth, Joan E Raymond, Russell E Sapp, Shelly K Cabot, Catherine F Tcheng, James E Califf, Robert M Effron, Mark B Topol, Eric J